Sen. John Hoeven sold AbbVie (ABBV)

Sen. John Hoeven (R-ND) · $100K–$250K · traded Jan 20, 2017

Transaction: Sold (full)
Amount: $100K–$250K
Owner: The member
Traded: Jan 20, 2017
Disclosed: Jan 25, 2017
Days to disclose: 5
Asset type: Stock
As filed: AbbVie Inc.
Industry: Drug Manufacturers - General · Healthcare

Official filing ↗All of Hoeven's trades All Congress trades in ABBV

Other trades in this filing

DisclosedTradeAmount

Jan 25, 2017
Sold (full) Merck & Co. MRK
$50K–$100K · Traded Jan 25, 2017 · disclosed Jan 25, 2017
$50K–$100K
Jan 25, 2017
Bought Willis Towers Watson Public Limited Company WTW
$50K–$100K · Traded Jan 24, 2017 · disclosed Jan 25, 2017
$50K–$100K
Jan 25, 2017
Bought V.F. VFC
$50K–$100K · Traded Jan 23, 2017 · disclosed Jan 25, 2017
$50K–$100K
Jan 25, 2017
Bought Cisco Systems CSCO
$100K–$250K · Traded Jan 20, 2017 · disclosed Jan 25, 2017
$100K–$250K
Jan 25, 2017
Bought Verizon Communications VZ
$50K–$100K · Traded Jan 20, 2017 · disclosed Jan 25, 2017
$50K–$100K
Jan 25, 2017
Sold (full) Johnson & Johnson JNJ
$100K–$250K · Traded Jan 20, 2017 · disclosed Jan 25, 2017
$100K–$250K
Jan 25, 2017
Sold (full) Pfizer PFE
$50K–$100K · Traded Jan 20, 2017 · disclosed Jan 25, 2017
$50K–$100K
Jan 25, 2017
Bought Intel INTC
$50K–$100K · Traded Jan 20, 2017 · disclosed Jan 25, 2017
$50K–$100K
Jan 25, 2017
Bought The Procter & Gamble Company PG
$100K–$250K · Traded Jan 20, 2017 · disclosed Jan 25, 2017
$100K–$250K
Jan 25, 2017
Bought The Coca-Cola Company KO
$100K–$250K · Traded Jan 20, 2017 · disclosed Jan 25, 2017
$100K–$250K
Jan 25, 2017
Sold (full) Bristol-Myers Squibb Company BMY
$50K–$100K · Traded Jan 20, 2017 · disclosed Jan 25, 2017
$50K–$100K
Jan 25, 2017
Bought PepsiCo PEP
$100K–$250K · Traded Jan 20, 2017 · disclosed Jan 25, 2017
$100K–$250K
Jan 25, 2017
Sold (full) Amgen AMGN
$50K–$100K · Traded Jan 20, 2017 · disclosed Jan 25, 2017
$50K–$100K
Jan 25, 2017
Bought AT&T T
$50K–$100K · Traded Jan 20, 2017 · disclosed Jan 25, 2017
$50K–$100K
Jan 25, 2017
Sold (full) THE CAMPBELL FUND TRUST - SERIES A Company: THE CAMPBELL FUND TRUST - SERIES A (BALTIMORE, MARYLAND) Description: INVETMENT MANAGEMENT IN FUTURES AND CASH EQUITY STRATEGIES
$50K–$100K · Traded Jan 12, 2017 · disclosed Jan 25, 2017
$50K–$100K

Recent Congress trades in ABBV

DisclosedTradeAmount

Oct 9, 2026
Rep. Ro Khanna (D-CA-17)
Sold AbbVie ABBV
$15K–$50K · Traded Sep 4, 2026 · disclosed Oct 9, 2026 · Spouse
$15K–$50K
Sep 21, 2026
Rep. Pete Sessions (R-TX-17)
Sold AbbVie ABBV
$15K–$50K · Traded Sep 14, 2026 · disclosed Sep 21, 2026
$15K–$50K
Jul 21, 2026
Sen. Alan Armstrong (R-OK)
Bought AbbVie ABBV
$15K–$50K · Traded Mar 27, 2026 · disclosed Jul 21, 2026 · filed 116 days later
Committee overlap: HELP
$15K–$50K
Jun 11, 2026
Rep. Ro Khanna (D-CA-17)
Bought AbbVie ABBV
$15K–$50K · Traded May 1, 2026 · disclosed Jun 11, 2026 · Dependent
$15K–$50K
Jun 4, 2026
Rep. Josh Gottheimer (D-NJ-5)
Sold (full) AbbVie ABBV
$1K–$15K · Traded May 5, 2026 · disclosed Jun 4, 2026 · Joint
$1K–$15K
Feb 10, 2026
Rep. Ro Khanna (D-CA-17)
Sold AbbVie ABBV
$15K–$50K · Traded Jan 29, 2026 · disclosed Feb 10, 2026 · Spouse
$15K–$50K
Jan 16, 2026
Rep. Julie Johnson (D-TX-32)
Sold (full) AbbVie ABBV
$1K–$15K · Traded Dec 18, 2025 · disclosed Jan 16, 2026 · Joint
$1K–$15K
Jan 13, 2026
Rep. Julia Letlow (R-LA-5)
Sold (full) AbbVie ABBV
$1K–$15K · Traded Dec 8, 2025 · disclosed Jan 13, 2026
$1K–$15K

From a periodic transaction report filed under the STOCK Act. Amounts are the ranges members report. Nothing here is investment advice.